GW597599B

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW597599B, covering 2017-10-09 to 2017-10-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder [Phase 2]